Savara Inc
SVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001160308
No open-market purchases or sales by Savara Inc insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Savara Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Savara Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Parker Braden C. | Chief Commercial Officer | 75,677 | Sep 25, 2026 | 1 |
| Lutz Robert Matthew | Chief Fin. & Operating Officer | 328,977 | Jul 24, 2026 | 2 |
| Lowrance David L | Chief Financial Officer | 536,032 | Jun 22, 2026 | 3 |
| McCracken Joseph S | Director | 302,644 | Feb 17, 2026 | 2 |
| Ramsay David A | Director | 2,533,642 | Dec 19, 2025 | 2 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER | 1,188,050 | Dec 16, 2025 | 2 |
| Erickson Anne | Chief Business Officer | 371,712 | Dec 16, 2025 | 1 |
| McCabe Kathleen R. | Chief Legal Officer | 519,232 | Dec 16, 2025 | 1 |
| Hawkins Richard J | Director | 161,326 | Dec 11, 2025 | 2 |
| Elam Nevan C | Director | 106,887 | Dec 11, 2025 | 2 |
| van Es-Johansson An | Director | 102,500 | Dec 11, 2025 | 1 |
| Wasfi Yasmine | Chief Medical Officer | 168,008 | Dec 4, 2025 | 2 |
| Pratt Raymond Dennis | Chief Medical Officer | 340,050 | Dec 16, 2024 | 0 |
| Sun Ricky | Director | 22,500 | Dec 15, 2023 | 0 |
| New Enterprise Associates 17, L.P. | 10% Owner | 24,471,264 | Jul 19, 2023 | 0 |
| Growth Equity Opportunities 17, LLC | 10% Owner | 24,471,264 | Jul 19, 2023 | 0 |
| NEA Partners 17, L.P. | 10% Owner | 24,471,264 | Jul 19, 2023 | 0 |
| Nea 17 GP, LLC | 10% Owner | 24,471,264 | Jul 19, 2023 | 0 |
| Sandell Scott D | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Baskett Forest | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Mathers Edward T | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Walker Paul Edward | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Behbahani Ali | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Makhzoumi Mohamad | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Chang Carmen | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Yang Rick | 10% Owner | 24,471,264Indirect | Jul 19, 2023 | 0 |
| Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | 300,000 | Dec 14, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 (view filing) | Dec 19 | Same day | Ramsay David ADirector | SSale | −20.0K | $6.06 | −$121.2K | −0.8%2.53M after | |
| Jun 22, 2026 (view filing) | Jun 22 | Same day | Lowrance David LChief Financial Officer | SSale | −394.5K | $5.68 | −$2.24M | −42.4%536.0K after |